Rezultati - Markus Raderer
- Showing 1 - 20 results of 70
- Go to Next Page
-
1
-
2
-
3
-
4
Palliative chemotherapy for advanced gastric cancer od Stefan Wöhrer, Markus Raderer, Michael Hejna
Izdano 2004Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma) od Barbara Kiesewetter, Marlene Troch, Werner Dolak, Leonhard Müllauer, Julius Lukas, C. Zielinski, Markus Raderer
Izdano 2012Artigo -
14
-
15
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma od Wolfgang Lamm, H. Kaufmann, Markus Raderer, M. Hoffmann, Andreas Chott, Christoph Zielinski, Johannes Drach
Izdano 2011Artigo -
16
-
17
-
18
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phas... od Andrés J.M. Ferreri, Marianna Sassone, Barbara Kiesewetter, Silvia Govi, Lydia Scarfò, Giovanni Donadoni, Markus Raderer
Izdano 2015Artigo -
19
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-typ... od M. Hoffmann, Kurt Kletter, Markus Diemling, Alexander Becherer, Franz Pfeffel, Ventzislav Petkov, Andreas Chott, Markus Raderer
Izdano 1999Artigo -
20
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: e... od Wolfgang Fischbach, Maria Elisabeth Goebeler, A. Ruskoné-Fourmestraux, Thomas Wündisch, Andreas Neubauer, Markus Raderer, Antonella Savio
Izdano 2007Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Lymphoma
Gastroenterology
Oncology
Pathology
MALT lymphoma
Surgery
Cancer
Chemotherapy
Immunology
Biology
Mucosa-associated lymphoid tissue
Clinical trial
Antibody
Clinical endpoint
Neuroendocrine tumors
Nuclear medicine
Positron emission tomography
Radiology
Lymphatic system
Rituximab
Multiple myeloma
Randomized controlled trial
B cell
Disease
Mantle cell lymphoma
Prospective cohort study
Adverse effect
Alternative medicine